XBiotech Inc. (XBIT)
↓ Download CSV- Sector Manufacturing
- Incorporated A1
- Fiscal year ends Dec 31
Key ratios (FY2025)
-32.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $4.01M | $18.39M | $44.00M | $0 | $0 | — | — |
| Cost of Revenue | — | — | $0 | $651.0K | $5.82M | $34.55M | $0 | $0 | — | — |
| Gross Profit | — | — | $0 | $3.36M | $12.57M | $9.45M | $0 | $0 | — | — |
| Operating Income | -$55.69M | -$42.47M | -$37.51M | -$34.49M | -$25.08M | -$18.28M | -$31.23M | -$20.99M | -$34.06M | -$52.76M |
| Net Income | -$45.54M | -$38.53M | -$24.56M | -$32.90M | -$17.41M | -$11.22M | $668.63M | -$21.14M | -$33.15M | -$52.76M |
| EPS (Diluted) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $14.44 | $-0.59 | $-0.95 | — |
| Total Assets | $150.08M | $199.09M | $226.62M | $246.10M | $275.18M | $353.74M | $816.88M | $44.34M | $62.97M | $67.05M |
| Total Liabilities | $9.73M | $16.82M | $7.77M | $5.70M | $5.79M | $5.11M | $61.25M | $2.95M | $2.81M | $7.99M |
| Shareholders' Equity | $140.35M | $182.27M | $218.85M | $240.40M | $269.38M | $348.64M | $755.63M | $41.40M | $60.16M | $59.06M |
| Cash & Equivalents | $125.55M | $172.68M | $200.02M | $157.31M | $236.98M | $237.37M | $714.59M | $15.82M | $31.77M | $34.32M |
| Operating Cash Flow | -$39.92M | -$30.96M | -$18.73M | -$14.82M | $69.44M | -$65.15M | -$18.27M | -$16.54M | -$33.65M | -$46.02M |
| Capital Expenditures | $289.0K | $1.30M | $362.0K | $585.0K | $3.52M | $3.73M | $204.0K | $122.0K | $1.41M | $4.75M |
| Shares Outstanding | 30.49M | 30.49M | 30.44M | 30.44M | 30.44M | 29.30M | 41.52M | 35.90M | 35.44M | 32.63M |